CONFIDENT: Supporting Long-term Care Workers During COVID-19
- Conditions
- COVID-19
- Interventions
- Behavioral: Social Media WebsiteOther: Enhanced Usual PracticeBehavioral: Dialogue-Based Webinar
- Registration Number
- NCT05168800
- Lead Sponsor
- Dartmouth-Hitchcock Medical Center
- Brief Summary
The CONFIDENT Study is an online three-arm randomized trial that aims to help long-term care workers in the United States feel more confident about the Coronavirus Disease 2019 (COVID-19) vaccines. The study will compare two different interventions to usual online information (website of the Centers for Disease Control and Prevention). The first intervention is a Dialogue-Based Webinar where people can interact and ask questions about the vaccines. The second intervention is a Social Media Website that will feature curated content about the vaccines from popular social media platforms.
Participants will be asked to completed four online surveys. The first survey will be completed pre-intervention and immediately upon study enrollment (Time 0). Participants will be randomized to a trial arm at the end of the Time 0 survey. Intervention follow-up surveys will be completed 3 weeks post-randomization (Time 1), three months post-randomization (Time 2), and 6 months post-randomization (Time 3).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2634
- at least 18 years of age
- can read, write, and understand English
- lives in the United States
- has worked in a long-term care setting in the past two years
- can provide information to confirm they have worked in a long-term care setting
- is not pregnant or breastfeeding
- at least somewhat worried about the COVID-19 vaccines and/or has not received a COVID-19 vaccine booster shot
- under 18 years of age
- cannot read, write, and understand English
- does not live in the United States
- has not worked in a long-term care setting in the past two years
- cannot provide information to confirm they have worked in a long-term care setting
- is pregnant or breastfeeding
- less than somewhat worried about the COVID-19 vaccines and has received at least one COVID-19 vaccine booster shot
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Social Media Website Social Media Website - Enhanced Usual Practice Enhanced Usual Practice - Dialogue-Based Webinar Dialogue-Based Webinar -
- Primary Outcome Measures
Name Time Method COVID-19 vaccine confidence 3 weeks post-randomization (Time 1) Confidence in the COVID-19 vaccines, assessed using the 3-item Vaccine Confidence Index (Larson et al., 2016) adapted for COVID-19. Each item is rated on a 5-point scale ranging from 1 ('Strongly disagree') to 5 ('Strongly agree'). Respondents are considered 'confident' (score of '1') if they respond 'Agree' or 'Strongly agree' on all three items and 'not confident' (score of '0') if one or more item responses is not 'Agree' or 'Strongly agree'.
- Secondary Outcome Measures
Name Time Method Likelihood of recommending COVID-19 vaccination 3 weeks post-randomization (Time 1) Likelihood of recommending COVID-19 vaccination to someone who is not vaccinated, assessed using a single-item adapted Net Promoter Score item. The item is assessed on an 11-point scale ranging from 0 ('No at all likely') to 10 ('Extremely likely').
COVID-19 vaccine intent (future vaccine recommendations) 3 weeks post-randomization (Time 1) Intent to get COVID-19 vaccines regularly in the future if they are recommended, assessed using a single item with multiple choice (single answer) format.
Change from baseline in secondary outcomes Baseline (Time 0); 3 weeks post-randomization (Time 1); 3 months post-randomization (Time 2); 6 months post-randomization (Time 3) Change in secondary outcomes from baseline, assessed using the same measures identified in Outcomes 3-13.
COVID-19 vaccine intent (initial series) 3 weeks post-randomization (Time 1) Intent to get a COVID-19 vaccine if unvaccinated, assessed using a single item with multiple choice (single answer) format.
COVID-19 vaccine intent (booster) 3 weeks post-randomization (Time 1) Intent to get a COVID-19 booster vaccine if not yet received, assessed using a single item with multiple choice (single answer) format.
As-treated analyses of primary and secondary outcomes Baseline (Time 0); 3 weeks post-randomization (Time 1); 3 months post-randomization (Time 2); 6 months post-randomization (Time 3) All primary and secondary outcomes assessed only for those who were exposed to their relevant study intervention and/or refresher intervention.
Change from baseline in COVID-19 vaccine confidence Baseline (Time 0); 3 weeks post-randomization (Time 1); 3 months post-randomization (Time 2); 6 months post-randomization (Time 3) Change in confidence in the COVID-19 vaccines from baseline, assessed using the 3-item Vaccine Confidence Index adapted for COVID-19.
Likelihood of recommending COVID-19 booster vaccination to coworker 3 weeks post-randomization (Time 1) Likelihood of recommending COVID-19 booster vaccination to a coworker, assessed using a single-item adapted Net Promoter Score item. The item is assessed on an 11-point scale ranging from 0 ('No at all likely') to 10 ('Extremely likely').
Feeling informed about the COVID-19 vaccines 3 weeks post-randomization (Time 1) Extent of feeling informed (having enough information and understanding that information) about the COVID-19 vaccines, using two self-developed items. Each item is assessed on a 5-point scale ranging from 0 ('No at all confident') to 4 ('Very confident').
Identification of COVID-19 vaccine information and misinformation 3 weeks post-randomization (Time 1) Identification of COVID-19 vaccine information and misinformation, assessed using four items. Some items self-developed and some adapted from Hamel et al., 2021 (see https://www.kff.org/coronavirus-covid-19/poll-finding/kff-covid-19-vaccine-monitor-media-and-misinformation/). Each item is assessed using a multiple choice (single answer) format.
COVID-19 vaccine uptake (any dose) 3 weeks post-randomization (Time 1) Receipt of any does of a COVID-19 vaccine, assessed using a single item with multiple choice (single answer) format.
COVID-19 vaccine uptake (initial series completion) 3 weeks post-randomization (Time 1) Completion of initial COVID-19 vaccine series, assessed using two items with multiple choice (single answer) formats.
Trust in COVID-19 vaccine information from different sources 3 weeks post-randomization (Time 1) Trust in COVID-19 vaccine information given by different people and organizations, assessed using a list of three different sources. Each source is assessed using a 4-point scale ranging from 0 ('Not at all') to 3 ('A lot').
COVID-19 vaccine uptake (booster completion) 3 weeks post-randomization (Time 1) Receipt of a COVID-19 booster vaccine if initial series completed, assessed using a single item with multiple choice (single answer) format.
Trial Locations
- Locations (1)
Dartmouth College
🇺🇸Lebanon, New Hampshire, United States